LEADER 04012nam  22006495  450 
001 9910416106703321
005 20220309130131.0
010   $a981-15-3658-9
024 7 $a10.1007/978-981-15-3658-8
035   $a(CKB)4100000011354667
035   $a(DE-He213)978-981-15-3658-8
035   $a(MiAaPQ)EBC6272294
035   $a(PPN)260304840
035   $a(EXLCZ)994100000011354667
100   $a20200720d2020      u|             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAntimicrobial Resistance$b[electronic resource] $eGlobal Challenges and Future Interventions /$fedited by Sabu Thomas
205   $a1st ed. 2020.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020.
215   $a1 online resource (XIII, 230 p. 20 illus., 16 illus. in color.)
311   $a981-15-3657-0 
327   $a1) The Evolution of Microbial Defense Systems against Antimicrobial Agents -- 2) Carbapenem Resistance in Gram-negative bacilli: Mechanisms and Challenges -- 3) Influence of Antimicrobials on the Gut Microbiota -- 4) Influence of Abiotic Factors in the Emergence of Antibiotic Resistance -- 5) Polluted Coastal and Estuarine Environments ? A Potential Reservoir for AMR Determinants in Various Pathogenic Bacteria -- 6) AMR in Animal Health: Issues and One Health Solutions for LMICs -- 7) Antifungal Resistance: Current Concepts -- 8) 'Planetary Health? Perspectives and Alternative Approaches to Tackle the AMR Challenge -- 9) Use of Bacterial Cell Wall Recycle Inhibitors to Combat AMR in Bacteria -- 10) Status quo of Omics Technologies in Analyzing the Genetic Mediators of Antimicrobial Resistance at Sub-MIC Concentrations.
330   $aAntimicrobial resistance is a major global public health problem. This book focuses on the clinical implications of multi-drug resistant pathogens; tracking AMR and its evolutionary significance; antifungal resistance; and current and alternative treatment strategies for AMR, including antivirulent, antibiofilm and antimicrobial resistance breakers, repurposing of drugs, and probiotic therapy. Advances in antimicrobial stewardship, antibiotic policies from a global perspective and their impacts are also discussed. The book also explores the use of omics approaches to gain insights into antibacterial resistance, and includes chapters on the potential benefits of a ?One Health approach? describing the environmental and zoonotic sources of resistant genes and their effects on the global resistance pool. .
606   $aPharmaceutical technology
606   $aPharmacy management
606   $aDrug resistance
606   $aMicrobiology
606   $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010
606   $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020
606   $aDrug Resistance$3https://scigraph.springernature.com/ontologies/product-market-codes/B16020
606   $aApplied Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/C12010
606   $aResistència als medicaments$2thub
606   $aMicrobiologia$2thub
608   $aLlibres electrònics$2thub
615  0$aPharmaceutical technology.
615  0$aPharmacy management.
615  0$aDrug resistance.
615  0$aMicrobiology.
615 14$aPharmaceutical Sciences/Technology.
615 24$aPharmacoeconomics and Health Outcomes.
615 24$aDrug Resistance.
615 24$aApplied Microbiology.
615  7$aResistència als medicaments
615  7$aMicrobiologia
676   $a615
702   $aThomas$b Sabu$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910416106703321
996   $aAntimicrobial Resistance$91935231
997   $aUNINA